These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2283261)

  • 1. Superparamagnetic contrast agents for magnetic resonance imaging.
    Gundersen HG; Bach-Gansmo T; Holtz E; Fahlvik AK; Berg A
    Invest Radiol; 1990 Sep; 25 Suppl 1():S67-8. PubMed ID: 2283261
    [No Abstract]   [Full Text] [Related]  

  • 2. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
    Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
    Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
    Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
    Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers.
    Päuser S; Reszka R; Wagner S; Wolf KJ; Buhr HJ; Berger G
    Anticancer Drug Des; 1997 Mar; 12(2):125-35. PubMed ID: 9113067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the development of magnetic particles for therapeutic applications.
    Barry SE
    Int J Hyperthermia; 2008 Sep; 24(6):451-66. PubMed ID: 18608583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.
    Yu MK; Jeong YY; Park J; Park S; Kim JW; Min JJ; Kim K; Jon S
    Angew Chem Int Ed Engl; 2008; 47(29):5362-5. PubMed ID: 18551493
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic transport of magnetic resonance imaging contrast agents. Ferrioxamine B derivatives.
    White DL; Eason RG; Alkire AL; Price DC; Hoener BA; Milco LA; Keen RE; Barnhart JL
    Invest Radiol; 1991 Nov; 26 Suppl 1():S146-7; discussion S150-5. PubMed ID: 1808112
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study.
    Lönnemark M; Hemmingsson A; Bach-Gansmo T; Ericsson A; Oksendal A; Nyman R; Moxnes A
    Acta Radiol; 1989; 30(2):193-6. PubMed ID: 2923745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.
    Lee PW; Hsu SH; Wang JJ; Tsai JS; Lin KJ; Wey SP; Chen FR; Lai CH; Yen TC; Sung HW
    Biomaterials; 2010 Feb; 31(6):1316-24. PubMed ID: 19959224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
    Majumdar S; Zoghbi S; Pope CF; Gore JC
    Radiology; 1988 Dec; 169(3):653-8. PubMed ID: 3186986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological properties of complex iron oxide nanoparticles entering in magnetic resonance tomography contrast agent].
    Akopdzhanov AG; Sergeev AI; Manvelov EV; Semeĭkin AV; Naumenko VIu; Panov VO; Bykov IV; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2010 Jun; 73(6):23-8. PubMed ID: 20726347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing effective transvascular particle delivery to the brain parenchyma: a challenge to neuroradiology.
    Quencer RM
    AJNR Am J Neuroradiol; 1999 Feb; 20(2):186. PubMed ID: 10094333
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers.
    Landmark KJ; Dimaggio S; Ward J; Kelly C; Vogt S; Hong S; Kotlyar A; Myc A; Thomas TP; Penner-Hahn JE; Baker JR; Holl MM; Orr BG
    ACS Nano; 2008 Apr; 2(4):773-83. PubMed ID: 19206610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for attachment of magnetic starch microspheres to Kupffer cells receptors in excised and perfused rat liver.
    Colet JM; Van Haverbeke Y; Muller RN
    Invest Radiol; 1994 Jun; 29 Suppl 2():S223-5. PubMed ID: 7928238
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
    Reimer P; Vosshenrich R
    Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents.
    Maity D; Zoppellaro G; Sedenkova V; Tucek J; Safarova K; Polakova K; Tomankova K; Diwoky C; Stollberger R; Machala L; Zboril R
    Chem Commun (Camb); 2012 Dec; 48(93):11398-400. PubMed ID: 23066527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
    Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
    Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
    Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
    Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI contrast agents: Classification and application (Review).
    Xiao YD; Paudel R; Liu J; Ma C; Zhang ZS; Zhou SK
    Int J Mol Med; 2016 Nov; 38(5):1319-1326. PubMed ID: 27666161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents.
    Rebolledo AF; Laurent S; Calero M; Villanueva A; Knobel M; Marco JF; Tartaj P
    ACS Nano; 2010 Apr; 4(4):2095-103. PubMed ID: 20355739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.